A novel mutation of the CYBB gene resulting in severe form of X-linked chronic granulomatous disease

Asian Pacific Journal of Allergy and Immunology

Volumn 25, Issue 4, 2007, Pages 249-252

  Jirapongsananuruk, Orathai ^a   Noack, Deborah ^b   Boonchoo, Siribangon ^a   Thepthai, Charin ^a   Chokephaibulkit, Kulkanya ^a   Visitsunthorn, Nualanong ^a   Vichyanond, Pakit ^a   Luangwedchakarn, Voravich ^a   Likasitwattanakul, Surachai ^a   Piboonpocanun, Surapon ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARGININE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; DIHYDRORHODAMINE 123; GLUTAMINE; GLYCINE; ITRACONAZOLE; PHENYLALANINE; PROTEIN CYBB; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TYROSINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; BRAIN BIOPSY; BRAIN INFECTION; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE INCREASE; FLOW CYTOMETRY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LYMPHADENITIS; MALE; NITROBLUE TETRAZOLIUM TEST; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PERIANAL ABSCESS; PNEUMONIA; PRESCHOOL CHILD; RISK FACTOR; SALMONELLOSIS; SEPTICEMIA; X LINKED CHRONIC GRANULOMATOUS DISEASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFANT; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; PNEUMONIA; SALMONELLA INFECTIONS; SEPSIS; SEQUENCE DELETION;

EID: 40749117265     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 2000; 79: 170-200.
2. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease, report on a national registry of 368 patients. Medicine 2000; 79: 155-69 !
3. Vowells SJ, Fleisher TA, Sekhsaria S, Alling DW, Maguire TE, Malech HL. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in, patients with chronic granulomatous disease. J Pediatr 1996; 128: 104-7.
4. Jirapongsananuruk O, Malech HL, Kuhns DB, et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol 2003; 111: 374-9.
5. Heyworth PG, Cumutte JT, Rae J, et al. Hematologically important mutations: X-linked chronic granulomatous disease (second update). Blood Cells Mol Dis 2001; 27: 16-26.
6. Roos D, Cumutte JT, Hossle JP, et al. X-CGDbase: A data-base of X-CGD-causing mutations. Immunol Today 1996; 17:517-21.
7. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995; 178: 89-97.